Riskpilot← Back to searchSign inGet full accessGULDSMED SUREL ApS
APSActiveCVR 31363470Vestergade 34Retail sale of watches and jewellery · NACE 4777Est. 200810 employees
Revenue 2025
DKK 1,6M
+76% vs 2024
EBITDA margin
-8.1%
+84% vs 2024
Equity ratio
35.1%
Financial strength
Net profit 2025
DKK -141K
+83% vs 2024
| Revenue | DKK 1,6M | +76% |
| EBITDA | DKK -128K | +84% |
| Net profit | DKK -141K | +83% |
| Total assets | DKK 5,6M | -20% |
| Equity | DKK 2M | -7% |
| Employees | 10 | — |
Legal name
GULDSMED SUREL ApS
CVR number
31363470
Legal form
Anpartsselskab
NACE code
4777 · Retail sale of watches and jewellery
Founded
13. marts 2008
Share capital
DKK 500.000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive handel og fabrikation samt hvad, der i øvrigt står i forbindelse hermed.
Address
Vestergade 34
Phone
+4566121645
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.019 | 2.026 | 2.015 | 2.068 | 2.033 | 1.573 | 1.168 | 815 | 980 | 1.568 | 1.212 | 1.096 | 892 | 1.574 |
| Staff expenses | -1.945 | -1.974 | -1.915 | -2.061 | -2.100 | -2.064 | -1.729 | -1.403 | -1.344 | -1.406 | -1.389 | -1.529 | -1.664 | -1.701 |
| EBITDA | 74 | 52 | 100 | 7 | -67 | -492 | -560 | -588 | -364 | 162 | -176 | -450 | -804 | -128 |
| Depreciation & amort. | -39 | -32 | -47 | -36 | -39 | -260 | -31 | -28 | -39 | -44 | -46 | -32 | -31 | -13 |
| EBIT | 35 | 20 | 53 | -29 | -105 | -752 | -591 | -616 | -403 | 118 | -222 | -482 | -835 | -140 |
| Net financials | -181 | -110 | -110 | -136 | -143 | -205 | -183 | -166 | -158 | -110 | -56 | -87 | -145 | -38 |
| Profit before tax | -37 | -53 | -57 | -166 | -248 | -957 | -775 | -783 | -562 | 8 | -278 | -569 | -980 | -179 |
| Tax | 55 | 18 | -5 | -23 | -55 | -8 | -0 | -0 | -0 | -31 | -22 | -767 | -130 | -38 |
| Net profit | -92 | -71 | -52 | -142 | -193 | -949 | -775 | -783 | -562 | 39 | -256 | 197 | -850 | -141 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.491 | 7.530 | 7.796 | 8.201 | 8.553 | 8.178 | 8.318 | 7.495 | 6.924 | 6.430 | 6.796 | 7.049 | 7.022 | 5.635 |
| Equity | 1.998 | 5.285 | 5.234 | 5.092 | 4.898 | 5.107 | 4.332 | 3.549 | 2.988 | 3.027 | 2.771 | 2.968 | 2.118 | 1.978 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 186 | 151 | 116 | 120 | 124 |
| Short-term debt | 5.493 | 2.245 | 2.562 | 3.110 | 3.655 | 3.072 | 3.986 | 3.946 | 3.847 | 3.217 | 3.874 | 3.964 | 4.784 | 3.534 |
| Total debt | 5.493 | 2.245 | 2.562 | 3.110 | 3.655 | 3.072 | 3.986 | 3.946 | 3.936 | 3.403 | 4.025 | 4.081 | 4.904 | 3.657 |
EBITDA margin
-8.1%
This company
15.8%
Market median
-151% vs market
20122025
Equity ratio
35.1%
This company
38.2%
Market median
+8% vs market
20122025
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
20122025
Net profit margin
-8.9%
This company
8.1%
Market median
-210% vs market
20122025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122025
Debt / equity
1.85×
This company
0.62×
Market median
-198% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2008 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
GULDSMED SUREL HOLDING ApS | Company | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GULDSMED SUREL HOLDING ApS
GULDSMED SUREL ApS Board members of GULDSMED SUREL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annette Hoppe Surel | Management | 0 companies |
| Liss Edel Henny Hoppe Surel | Chairman | 0 companies |
| Helene Jeanett Surel Jenlev | Board of Directors | 0 companies |
| Iben Lindhardt Fechtenburg | Board of Directors | 0 companies |
| Erik Stærmose Jenlev | Chairman | 0 companies |